Evidence map›Paper›PMID 20189619›Full record

ArticleSurgery2010

Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury.

Mark R Hemmila, Aladdein Mattar, Michael A Taddonio, Saman Arbabi, Tarek Hamouda, Peter A Ward, Stewart C Wang, James R Baker

Abstract read
In one paragraph

Article in Surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dermal Nanoemulsion Treatment Reduces Burn Wound Conversion and Improves Skin Healing in a Porcine Model of Thermal Burn Injury.Journal of burn care & research : official publication of the American Burn Association · 2021
    Article
  6. Review
  7. Review
  8. Review
  9. Antibacterial potential of essential oils ofIranian journal of microbiology · 2020
    Article
  10. Article
  11. Article
  12. EVALUATION OF EFFECTIVENESS IN A NOVEL WOUND HEALING OINTMENT-CROCODILE OIL BURN OINTMENT.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2017
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Animal models in burn research.Cellular and molecular life sciences : CMLS · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mark R HemmilaDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109-5033, USA. mhemmila@umich.edu
Aladdein Mattar
Michael A Taddonio
Saman Arbabi
Tarek Hamouda
Peter A Ward
Stewart C Wang
James R Baker
University of Michigan–Ann Arbor · USNanoBio (United States) · USUniversity of Washington Medical Center · US

Funding

Gram-Negative Pneumonia and Lipopolysaccharide Binding ProteinK08GM078610 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEMMILA, MARK RICHARD · 2006 to 2010
$643k
NIGMS NIH HHS K08 GM078610NIGMS NIH HHS K08-GM078610
6 · The paper itself

Abstract

backgroundNanoemulsions are broadly antimicrobial oil-in-water emulsions containing nanometer-sized droplets stabilized with surfactants. We hypothesize that topical application of a nanoemulsion compound (NB-201) can attenuate burn wound infection. In addition to reducing infection, nanoemulsion therapy may modulate dermal inflammatory signaling and thereby lessen inflammation following thermal injury.

methodsMale Sprague-Dawley rats underwent a 20% total body surface area scald burn to create a partial-thickness burn injury. Animals were resuscitated with Ringer's lactate solution and the wound covered with an occlusive dressing. At 8 hours after injury, the burn wound was inoculated with 1 x 10(6) colony-forming units (CFUs) of Pseudomonas aeruginosa. NB-201, NB-201 placebo, 5% mafenide acetate solution, or 0.9% saline (control) was applied onto the wound at 16 and 24 hours after burn injury. Skin was harvested 32 hours postburn for quantitative wound culture and determination of inflammatory mediators in tissue homogenates.

resultsNB-201 decreased mean bacterial growth in the burn wound by 1,000-fold, with only 13% (3/23) of animals having P. aeruginosa counts greater than 10(5) CFU/g tissue versus 91% (29/32) in the control group (P < .0001). Treatment with NB-201 attenuated neutrophil sequestration in the treatment group as measured by myeloperoxidase assay and by histology. It also significantly decreased levels of proinflammatory cytokines (interleukin [IL]-1beta and IL-6) and the degree of hair follicle cell apoptosis in skin compared to saline-treated controls.

conclusionTopical NB-201 substantially decreased bacterial growth in a partial-thickness burn model. This decrease in the level of wound infection was associated with an attenuation of the local dermal inflammatory response and diminished neutrophil sequestration. NB-201 represents a novel potent antimicrobial and anti-inflammatory treatment for use in burn wounds.

Indexed as

AnimalsApoptosisBacterial InfectionsBiomarkersBurnsEmulsionsHot TemperatureHumansInflammationInterleukin-1betaInterleukin-6MalePeroxidasePseudomonas aeruginosaPseudomonas InfectionsRatsBiomarkersEmulsionsInterleukin-1betaInterleukin-6Peroxidase

Identifiers

PMID20189619
PMCPMC2891388
OpenAlexW2001194276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.